WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006089656) PHARMACEUTICAL AEROSOL FORMULATIONS FOR PRESSURIZED METERED DOSE INHALERS COMPRISING A SEQUESTERING AGENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/089656    International Application No.:    PCT/EP2006/001287
Publication Date: 31.08.2006 International Filing Date: 13.02.2006
IPC:
A61K 9/12 (2006.01), A61K 9/72 (2006.01), A61K 47/02 (2006.01), A61K 31/573 (2006.01), A61K 31/58 (2006.01), A61K 31/4704 (2006.01)
Applicants: CHIESI FARMACEUTICI S.P.A. [IT/IT]; Via Palermo 26/a, I-43100 Parma (IT) (For All Designated States Except US).
LEWIS, David Andrew [GB/GB]; (IT) (For US Only).
MEAKIN, Brian John [GB/GB]; (IT) (For US Only).
DELCANALE, Maurizio [IT/IT]; (IT) (For US Only).
PIVETTI, Fausto [IT/IT]; (IT) (For US Only)
Inventors: LEWIS, David Andrew; (IT).
MEAKIN, Brian John; (IT).
DELCANALE, Maurizio; (IT).
PIVETTI, Fausto; (IT)
Agent: ADAM, Holger; Kraus & Weisert, Thomas-Wimmer-Ring 15, 80539 München (DE)
Priority Data:
05004233.2 25.02.2005 EP
Title (EN) PHARMACEUTICAL AEROSOL FORMULATIONS FOR PRESSURIZED METERED DOSE INHALERS COMPRISING A SEQUESTERING AGENT
(FR) PREPARATIONS PHARMACEUTIQUES D'AEROSOL POUR AEROSOLS-DOSEURS PRESSURISES CONTENANT UN AGENT SEQUESTRANT
Abstract: front page image
(EN)Aerosol solution formulation for use in an aerosol inhaler which comprises at least one active ingredient selected from a group consisting of 20-ketosteroids and quinolinone derivatives, a propellant containing a hydrofluoroalkane, and a cosolvent, stabilized by addition of a specific amount of a sequestering agent.
(FR)La présente invention se rapporte à une préparation de solution pour aérosol destinée à être utilisée dans un inhalateur aérosol, qui contient au moins un ingrédient actif sélectionné parmi les 20-cétostéroïdes et les dérivés de la quinolinone, un propulseur contenant un hydrofluoroalcane et un cosolvant, stabilisés par l'ajout d'une dose spécifique d'un agent séquestrant.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)